BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:Pacific Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:Pacific Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260813T163000 DTEND;TZID=America/Los_Angeles:20260813T190000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Commuter Conference: From Discovery to Impact DESCRIPTION:Join us for an exclusive look inside Bayer's Building 69\, the Cell Therapy Launch Facility\, and explore the critical role advanced research and manufacturing facilities play in bringing innovative therapies to patients.This unique program brings together leaders from across the Parkinson's ecosystem to provide a 360-degree perspective on the journey from scientific discovery to patient impact. We'll begin with an overview of Building 69 and its role in supporting the development and production of next-generation cell therapies aimed at addressing Parkinson's disease. Representatives from the Parkinson's Foundation will then provide insight into the disease itself\, including its challenges\, prevalence\, and impact on patients and families. The evening will conclude with a patient perspective\, highlighting the real-world importance of continued research\, development\, and investment in innovative treatment approaches.Through this conversation\, attendees will gain a deeper understanding of how facility development\, scientific advancement\, advocacy\, and patient experiences intersect to drive meaningful progress in healthcare.PRESENTERSIngo Stecher is a Venture Manager at Bayer Berkeley with more than 20 years of leadership experience in capital project delivery\, engineering\, and construction across the pharmaceutical and biotech industries. He served as Capital Expenditure Project Director for the Cell Culture Technology Center and Cell Therapy Launch Facility projects\, with full accountability for the end-to-end execution and delivery of Bayer's advanced cell therapy production facility in Berkeley.Scott Probst is a Cell and Gene Therapy Implementation Lead in Berkeley with nearly 30 years of process engineering experience at Bayer\, mostly in biopharmaceuticals. For the past seven years\, Scott has been working on development and commercialization of an allogeneic cell therapy for Parkinson's Disease with Bayer subsidiary and partner\, BlueRock Therapeutics.We'll also be joined by Steve and Lisa Fischlin\, California Board Members\, Parkinson's Foundation who will speak from the perspective of the patient.SPONSORSHIP OPPORTUNITIESHeadline Sponsorship $1000Includes:Up to 3 complimentary ticketsVerbal recognition during welcome remarksInclusion of 1 slide in the welcome remarks presentation (if a PowerPoint is used)Logo and/or name recognition on the event webpage and marketing materials.Food & Beverage Sponsor $550Includes:Up to 1 complimentary ticketVerbal recognition during welcome remarksLogo and/or name recognition on the event webpage and marketing materials. X-ALT-DESC;FMTTYPE=text/html:


Join us for an exclusive look inside Bayer'\;s Building 69\, the Cell Therapy Launch Facility\, and explore the critical role advanced research and manufacturing facilities play in bringing innovative therapies to patients.

This unique program brings together leaders from across the Parkinson'\;s ecosystem to provide a 360-degree perspective on the journey from scientific discovery to patient impact. We'\;ll begin with an overview of Building 69 and its role in supporting the development and production of next-generation cell therapies aimed at addressing Parkinson'\;s disease. Representatives from the Parkinson'\;s Foundation will then provide insight into the disease itself\, including its challenges\, prevalence\, and impact on patients and families. The evening will conclude with a patient perspective\, highlighting the real-world importance of continued research\, development\, and investment in innovative treatment approaches.

Through this conversation\, attendees will gain a deeper understanding of how facility development\, scientific advancement\, advocacy\, and patient experiences intersect to drive meaningful progress in healthcare.

PRESENTERS

Ingo Stecher is a Venture Manager at Bayer Berkeley with more than 20 years of leadership experience in capital project delivery\, engineering\, and construction across the pharmaceutical and biotech industries. He served as Capital Expenditure Project Director for the Cell Culture Technology Center and Cell Therapy Launch Facility projects\, with full accountability for the end-to-end execution and delivery of Bayer&rsquo\;s advanced cell therapy production facility in Berkeley.

Scott Probst is a Cell and Gene Therapy Implementation Lead in Berkeley with nearly 30 years of process engineering experience at Bayer\, mostly in biopharmaceuticals.  \;For the past seven years\, Scott has been working on development and commercialization of an allogeneic cell therapy for Parkinson&rsquo\;s Disease with Bayer subsidiary and partner\, BlueRock Therapeutics.

We'\;ll also be joined by Steve and Lisa Fischlin\, California Board Members\, Parkinson'\;s Foundation who will speak from the perspective of the patient.

SPONSORSHIP OPPORTUNITIES

Headline Sponsorship &ndash\; $1000

Includes:

  1. Up to 3 complimentary tickets
  2. Verbal recognition during welcome remarks
  3. Inclusion of 1 slide in the welcome remarks presentation (if a PowerPoint is used)
  4. Logo and/or name recognition on the event webpage and marketing materials.

Food &\; Beverage Sponsor &ndash\; $550

Includes:

  1. Up to 1 complimentary ticket
  2. Verbal recognition during welcome remarks
  3. Logo and/or name recognition on the event webpage and marketing materials.
LOCATION:800 Dwight Way Berkeley CA 94710 UID:e.4613.1459856 SEQUENCE:3 DTSTAMP:20260726T175516Z URL:https://internationalsocietyofpharmaceuticalengineers.growthzoneapp.com/bod-calendar/Details/commuter-conference-from-discovery-to-impact-1729181?sourceTypeId=Hub END:VEVENT END:VCALENDAR